img

Oligonucleotide DNA Microarrays (oDNA) Market Status and Trend Analysis 2017-2026 (COVID-19 Version)


Published on: 2020-11-30 | No of Pages : 92 | Industry : Electronics & Semiconductor

Publisher : 9 | Format : PDF

Oligonucleotide DNA Microarrays (oDNA) Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Oligonucleotide DNA Microarrays (oDNA) market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Oligonucleotide DNA Microarrays (oDNA) market segmented into
Gene expression
Genotyping
Genome cytogenetics

Based on the end-use, the global Oligonucleotide DNA Microarrays (oDNA) market classified into
Oncology
Non-invasive pregnancy testing(NIPT)
Hypertension
diabetes
Nervous system diseases
Others

Based on geography, the global Oligonucleotide DNA Microarrays (oDNA) market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
Illumnia
Affymetrix
Agilent
Scienion AG
Applied Microarrays
Arrayit
Sengenics
Biometrix Technology
Savyon Diagnostics
WaferGen

Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL OLIGONUCLEOTIDE DNA MICROARRAYS (ODNA) INDUSTRY
2.1 Summary about Oligonucleotide DNA Microarrays (oDNA) Industry
2.2 Oligonucleotide DNA Microarrays (oDNA) Market Trends
2.2.1 Oligonucleotide DNA Microarrays (oDNA) Production & Consumption Trends
2.2.2 Oligonucleotide DNA Microarrays (oDNA) Demand Structure Trends
2.3 Oligonucleotide DNA Microarrays (oDNA) Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Gene expression
4.2.2 Genotyping
4.2.3 Genome cytogenetics
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Oncology
4.3.2 Non-invasive pregnancy testing(NIPT)
4.3.3 Hypertension
4.3.4 diabetes
4.3.5 Nervous system diseases
4.3.6 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Gene expression
5.2.2 Genotyping
5.2.3 Genome cytogenetics
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Oncology
5.3.2 Non-invasive pregnancy testing(NIPT)
5.3.3 Hypertension
5.3.4 diabetes
5.3.5 Nervous system diseases
5.3.6 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Gene expression
6.2.2 Genotyping
6.2.3 Genome cytogenetics
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Oncology
6.3.2 Non-invasive pregnancy testing(NIPT)
6.3.3 Hypertension
6.3.4 diabetes
6.3.5 Nervous system diseases
6.3.6 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Gene expression
7.2.2 Genotyping
7.2.3 Genome cytogenetics
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Oncology
7.3.2 Non-invasive pregnancy testing(NIPT)
7.3.3 Hypertension
7.3.4 diabetes
7.3.5 Nervous system diseases
7.3.6 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Gene expression
8.2.2 Genotyping
8.2.3 Genome cytogenetics
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Oncology
8.3.2 Non-invasive pregnancy testing(NIPT)
8.3.3 Hypertension
8.3.4 diabetes
8.3.5 Nervous system diseases
8.3.6 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Gene expression
9.2.2 Genotyping
9.2.3 Genome cytogenetics
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Oncology
9.3.2 Non-invasive pregnancy testing(NIPT)
9.3.3 Hypertension
9.3.4 diabetes
9.3.5 Nervous system diseases
9.3.6 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Illumnia
10.1.2 Affymetrix
10.1.3 Agilent
10.1.4 Scienion AG
10.1.5 Applied Microarrays
10.1.6 Arrayit
10.1.7 Sengenics
10.1.8 Biometrix Technology
10.1.9 Savyon Diagnostics
10.1.10 WaferGen
10.2 Oligonucleotide DNA Microarrays (oDNA) Sales Date of Major Players (2017-2020e)
10.2.1 Illumnia
10.2.2 Affymetrix
10.2.3 Agilent
10.2.4 Scienion AG
10.2.5 Applied Microarrays
10.2.6 Arrayit
10.2.7 Sengenics
10.2.8 Biometrix Technology
10.2.9 Savyon Diagnostics
10.2.10 WaferGen
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
Table Oligonucleotide DNA Microarrays (oDNA) Product Type Overview
Table Oligonucleotide DNA Microarrays (oDNA) Product Type Market Share List
Table Oligonucleotide DNA Microarrays (oDNA) Product Type of Major Players
Table Brief Introduction of Illumnia
Table Brief Introduction of Affymetrix
Table Brief Introduction of Agilent
Table Brief Introduction of Scienion AG
Table Brief Introduction of Applied Microarrays
Table Brief Introduction of Arrayit
Table Brief Introduction of Sengenics
Table Brief Introduction of Biometrix Technology
Table Brief Introduction of Savyon Diagnostics
Table Brief Introduction of WaferGen
Table Products & Services of Illumnia
Table Products & Services of Affymetrix
Table Products & Services of Agilent
Table Products & Services of Scienion AG
Table Products & Services of Applied Microarrays
Table Products & Services of Arrayit
Table Products & Services of Sengenics
Table Products & Services of Biometrix Technology
Table Products & Services of Savyon Diagnostics
Table Products & Services of WaferGen
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Oligonucleotide DNA Microarrays (oDNA) Market Forecast (Million USD) by Region 2021f-2026f
Table Global Oligonucleotide DNA Microarrays (oDNA) Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Oligonucleotide DNA Microarrays (oDNA) Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Oligonucleotide DNA Microarrays (oDNA) Market Forecast (Million USD) Share by Demand 2021f-2026f